Details for New Drug Application (NDA): 203621
✉ Email this page to a colleague
The generic ingredient in NYSTATIN is nystatin; triamcinolone acetonide. There are eight drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the nystatin; triamcinolone acetonide profile page.
Summary for 203621
Tradename: | NYSTATIN |
Applicant: | Pharm Assoc |
Ingredient: | nystatin |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Suppliers and Packaging for NDA: 203621
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
NYSTATIN | nystatin | SUSPENSION;ORAL | 203621 | ANDA | Pharmaceutical Associates, Inc. | 0121-0810 | 0121-0810-02 | 60 mL in 1 BOTTLE, DROPPER (0121-0810-02) |
NYSTATIN | nystatin | SUSPENSION;ORAL | 203621 | ANDA | Pharmaceutical Associates, Inc. | 0121-0810 | 0121-0810-16 | 473 mL in 1 BOTTLE (0121-0810-16) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SUSPENSION;ORAL | Strength | 100,000 UNITS/ML | ||||
Approval Date: | Jan 7, 2016 | TE: | AA | RLD: | No |
Complete Access Available with Subscription